Profile
Matthew R.
Kane is the founder of Precision BioSciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2006 to 2021.
The current job is Non-Executive Director at Celyad Oncology SA starting in 2024.
Former jobs include Chief Executive Officer & Director at Tune Therapeutics, Inc. and Principal at Suros Surgical Systems, Inc. Education history includes an MBA from Duke University and graduate studies at Rose-Hulman Institute of Technology, Inc.
Matthew Kane active positions
| Companies | Position | Start |
|---|---|---|
| CELYAD ONCOLOGY SA | Director/Board Member | - |
Former positions of Matthew Kane
| Companies | Position | End |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Founder | 15/10/2021 |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Chief Executive Officer | - |
Suros Surgical Systems, Inc.
Suros Surgical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Corporate Officer/Principal | - |
Training of Matthew Kane
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Suros Surgical Systems, Inc.
Suros Surgical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rose-Hulman Institute of Technology, Inc.
Rose-Hulman Institute of Technology, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Health Technology |
- Stock Market
- Insiders
- Matthew Kane
















